MedTrace Logo

TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure

NCT05250349 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-02-22

No results posted yet for this study

Summary

TRACE-IMPAIR is a prospective, clinical study of consecutive patients that evaluates the relationship between heart failure (HF) and cognitive impairment in relation to carotid and cerebral flow. The carotid and cerebral flow will be assessed using Doppler ultrasonography, and cognitive function will be estimated during routine neuropsychological tests.

It is an observational, three(natural)-group, single-center study. It is also an Academic Registry - the scientific activity of the Faculty of Medicine, Collegium Medicum, Jagiellonian University, and John Paul II Hospital.

Conditions

Interventions

DIAGNOSTIC_TEST

Echocardiography

Transthoracic echocardiography with standard measurements

DIAGNOSTIC_TEST

Doppler sonography

Transcarotid and transcranial Doppler sonography

DIAGNOSTIC_TEST

Neuropsychological tests

Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA)

Sponsors & Collaborators

  • John Paul II Hospital, Krakow

    lead OTHER

Principal Investigators

  • Piotr Musialek, MD, DPhil · John Paul II Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-09-01
Completion
2027-09-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05250349 on ClinicalTrials.gov